ACP Injection 2 mg/ml: Further information
|
ACP Injection 2 mg/ml
Further information
Subcutaneous injection is non irritant and efficacious, especially in cats.
Use during pregnancy, lactation or lay
No formal studies on the safety of ACP Injection in pregnant animals have been conducted (see section 4.3, Contraindications).
Interaction with other medicinal products and other forms of interaction
Acepromazine is additive to the actions of other depressants and will potentiate general anaesthesia (see section 4.2, indications for use).
PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Antipsychotics
ATC vet code: QN05AA04
Pharmacodynamic Properties
Acepromazine is a phenothiazine. It is a central nervous system depressant with associated activity on the autonomic system. Phenothiazines have a central action due to inhibition of dopamine pathways, resulting in alteration of mood, reduction in fear and removal of learned or conditioned responses.
Acepromazine possesses anti-emetic, hypthermic, hypotensive and anti-spasmodic properties and shows a marked potentiating effect on barbiturate anaesthesia.
Pharmacokinetic Particulars
The length of action of acepromazine appears to be prolonged and to be dose dependant.
PHARMACEUTICAL PARTICULARS
List of excipients:
Phenol
Sodium hydroxide or
Maleic acid
Water for injections
Incompatibilities
None known
Shelf Life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years
|
 |
 
        |
 |
|
|
|
|||||||||||||||||||||||||
Date updated: 11 October 2012